Management of generalised convulsive status epilepticus (SE): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam – Pilot study

2015 ◽  
Vol 114 ◽  
pp. 52-58 ◽  
Author(s):  
R.C. Mundlamuri ◽  
S. Sinha ◽  
D.K. Subbakrishna ◽  
P.V. Prathyusha ◽  
M. Nagappa ◽  
...  
Keyword(s):  
Status Epilepticus ◽  
Pilot Study ◽  
Sodium Valproate ◽  
Combined Treatment ◽  
Controlled Study ◽  
Convulsive Status Epilepticus ◽  
Randomised Controlled Study ◽  
Phenytoin Sodium ◽  
Randomised Controlled

scholarly journals The Status of Intravenous Valproate for Status

2007 ◽  
Vol 7 (4) ◽  
pp. 96-98 ◽  
Author(s):  
Lawrence J. Hirsch
Keyword(s):  
Status Epilepticus ◽  
Pilot Study ◽  
Side Effects ◽  
Sodium Valproate ◽  
Convulsive Status Epilepticus ◽  
The Status

Sodium Valproate vs Phenytoin in Status Epilepticus: A Pilot Study. Misra UK, Kalita J, Patel R. Neurology 2006;67(2):340–342. Sixty-eight patients with convulsive status epilepticus (SE) were randomly assigned to two groups to study the efficacy of sodium valproate (VPA) and phenytoin (PHT). Seizures were aborted in 66% in the VPA group and 42% in the PHT group. As a second choice in refractory patients, VPA was effective in 79% and PHT was effective in 25%. The side effects in the two groups did not differ. Sodium valproate may be preferred in convulsive SE because of its higher efficacy.

scholarly journals Comparing the efficacy of sodium valproate and levetiracetam following initial lorazepam in elderly patients with generalized convulsive status epilepticus (GCSE): A prospective randomized controlled pilot study

Seizure ◽  
2019 ◽  
Vol 65 ◽  
pp. 111-117 ◽  
Author(s):  
Devavrat Nene ◽  
Ravindranadh Chowdary Mundlamuri ◽  
Parthasarathy Satishchandra ◽  
Parthipulli Vasuki Prathyusha ◽  
Madhu Nagappa ◽  
...  
Keyword(s):  
Status Epilepticus ◽  
Pilot Study ◽  
Elderly Patients ◽  
Sodium Valproate ◽  
Convulsive Status Epilepticus ◽  
Randomized Controlled

EFFECTS OF “HOE HOA TAN II” REMEDY IN THE TREATMENT OF INTERNAL HAEMORROHIDS GRADE I, II AND III

2015 ◽  
pp. 80-85
Author(s):  
Van Anh Nguyen ◽  
Van Nhan Le ◽  
Nguyen Nhu Phuong Phan
Keyword(s):  
Side Effects ◽  
Key Words ◽  
Patient Group ◽  
Controlled Study ◽  
Therapeutic Effects ◽  
Radix Angelicae Sinensis ◽  
Randomised Controlled Study ◽  
Citrus Deliciosa ◽  
Randomised Controlled ◽  
Angelicae Sinensis

Objectives: To investigate and evaluate the therapeutic effects of Hoe hoa tan II in the treatment of internal haemorroids grade I, II and III. Ingredients of the remedy include: Hoe Hoa (Styphonolonium japonicum), Chi xac (Fructus citri Aurantii), Hau phac (Magnolia offinalis), Tran bi (Citrus deliciosa Tenore), Thuong thuat (Atractylodes lancea), O mai (Armeniaca vulgaris Lamk), Cam thao (Clycyrrhiza uralensis), Duong quy (Radix Angelicae Sinensis). Subjects and methods: Randomised controlled study (RCT) has been conducted on 60 patients which were divided into two groups, i.e. the first 30 patient group were treated with Hoe hoa tan II remedy 20 g, and the second 30 patient group were treated with Daflon 500 mg in the course of 14 days. Results: Study showed that Hoe hoa tan II has helped improve symptoms of internal haemorroids grade I, II and III such as bleeding, anal exudation, pain, reducing the size of the haemorroid tissues. The remedy has been shown to have the most significant effect on relieving constipation which is typical in haemorroids. The study also revealed no unwanted effects caused by this formula. Conclusion: Hoe hoa tan II can be therapeutically used to treat internal haemorroids grade I, II and III without causing any serious side effects. Key words: Hoe hoa tan II, internal haemorroids grade I, II, III.

Sign in / Sign up

Export Citation Format

Share Document